Gabapentin use and a claim for memory loss in Indiana

Indiana's heavy manufacturing economy produces high chronic pain rates that drive substantial gabapentin prescribing, particularly in industrial centers like Indianapolis, Fort Wayne, and the Gary-Hammond corridor. The state was severely impacted by the opioid crisis, and gabapentin prescribing surged as physicians sought alternatives for chronic pain patients whose opioid access was restricted. Indiana has not scheduled gabapentin as a controlled substance despite neighboring Ohio and Kentucky doing so. The state's Product Liability Act provides a framework for pharmaceutical claims, though Indiana's comparative fault system and certain statutory protections for manufacturers create a more defense-friendly environment than some neighboring states.

For the overall process and updates, read the Gabapentin use and a claim for memory loss overview. This page covers the local information available for Indiana.